Viral evasion strategies in type I IFN signaling - A summary of recent developments

Frontiers in Immunology

Volumn 7, Issue NOV, 2016, Pages

  Schulz, Katharina S ^a   Mossman, Karen L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Evasion; Innate immune signaling; NF B; Type I interferon; Virus

Indexed keywords

HEMAGGLUTININ; I KAPPA B KINASE; I KAPPA B KINASE GAMMA; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1BETA; JANUS KINASE 1; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 13; NONSTRUCTURAL PROTEIN 1; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; RECEPTOR INTERACTING PROTEIN 140; REPRESSOR PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UBIQUITIN PROTEIN LIGASE E3; VIRUS DNA; VIRUS RNA;

ANIMAL CELL; CELL MIGRATION; ENCEPHALOMYOCARDITIS VIRUS; EQUINE ARTERITIS VIRUS; FOOT AND MOUTH DISEASE VIRUS; GENE INDUCTION; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE EVASION; INNATE IMMUNITY; NONHUMAN; PHLEBOVIRUS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; RNA BINDING; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS INFECTION;

EID: 85006164562     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00498     Document Type: Review

References (126)

1. Nagarajan U. Induction and function of IFNbeta during viral and bacterial infection. Crit Rev Immunol (2011) 31(6):459-74. doi:10.1615/CritRevImmunol.v31.i6.20
2. Krug RM. Functions of the influenza A virus NS1 protein in antiviral defense. Curr Opin Virol (2015) 12:1-6. doi:10.1016/j.coviro.2015.01.007
3. Weber-Gerlach M, Weber F. To conquer the host, influenza virus is packing it in: interferon-antagonistic strategies beyond NS1. J Virol (2016) 90(19):8389-94. doi:10.1128/JVI.00041-16
4. Wuerth JD, Weber F. Phleboviruses and the type I interferon response. Viruses (2016) 8(6):174-90. doi:10.3390/v8060174
5. Amsler L, Verweij MC, DeFilippis VR. The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus. J Mol Biol (2013) 425(24):4857-71. doi:10.1016/j.jmb.2013.08.023
6. Kumari P, Narayanan S, Kumar H. Herpesviruses: interfering innate immunity by targeting viral sensing and interferon pathways. Rev Med Virol (2015) 25(3):187-201. doi:10.1002/rmv.1836
7. Su C, Zhan G, Zheng C. Evasion of host antiviral innate immunity by HSV-1, an update. Virol J (2016) 13:38. doi:10.1186/s12985-016-0495-5
8. Vijay R, Perlman S. Middle East respiratory syndrome and severe acute respiratory syndrome. Curr Opin Virol (2016) 16:70-6. doi:10.1016/j.coviro.2016.01.011
9. Rustagi A, Gale M Jr. Innate antiviral immune signaling, viral evasion and modulation by HIV-1. J Mol Biol (2014) 426(6):1161-77. doi:10.1016/j.jmb.2013.12.003
10. Sauter D, Kirchhoff F. HIV replication: a game of hide and sense. Curr Opin HIV AIDS (2016) 11(2):173-81. doi:10.1097/COH.0000000000000233
11. Zinzula L, Tramontano E. Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit. Antiviral Res (2013) 100(3):615-35. doi:10.1016/j.antiviral.2013.10.002
12. Chatterjee S, Basler CF, Amarasinghe GK, Leung DW. Molecular mechanisms of innate immune inhibition by non-segmented negative-sense RNA viruses. J Mol Biol (2016) 428(17):3467-82. doi:10.1016/j.jmb.2016.07.017
13. Goubau D, Deddouche S, Reis e Sousa C. Cytosolic sensing of viruses. Immunity (2013) 38(5):855-69. doi:10.1016/j.immuni.2013.05.007
14. Chan YK, Gack MU. Viral evasion of intracellular DNA and RNA sensing. Nat Rev Microbiol (2016) 14(6):360-73. doi:10.1038/nrmicro.2016.45
15. Lin D, Zhong B. Regulation of cellular innate antiviral signaling by ubiquitin modification. Acta Biochim Biophys Sin (Shanghai) (2015) 47(3):149-55. doi:10.1093/abbs/gmu133
16. Taylor KE, Mossman KL. Recent advances in understanding viral evasion of type I interferon. Immunology (2013) 138(3):190-7. doi:10.1111/imm.12038
17. Devasthanam AS. Mechanisms underlying the inhibition of interferon signaling by viruses. Virulence (2014) 5(2):270-7. doi:10.4161/viru.27902
18. Ma Z, Damania B. The cGAS-STING defense pathway and its counteraction by viruses. Cell Host Microbe (2016) 19(2):150-8. doi:10.1016/j.chom.2016.01.010
19. Kell AM, Gale M Jr. RIG-I in RNA virus recognition. Virology (2015) 47(9-480):110-21. doi:10.1016/j.virol.2015.02.017
20. Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity (2007) 27(4):549-59. doi:10.1016/j.immuni.2007.10.002
21. Saito T, Hirai R, Loo YM, Owen D, Johnson CL, Sinha SC, et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A (2007) 104(2):582-7. doi:10.1073/pnas.0606699104
22. Fitzgerald ME, Rawling DC, Vela A, Pyle AM. An evolving arsenal: viral RNA detection by RIG-I-like receptors. Curr Opin Microbiol (2014) 20:76-81. doi:10.1016/j.mib.2014.05.004
23. Gack MU, Nistal-Villan E, Inn KS, Garcia-Sastre A, Jung JU. Phosphorylation-mediated negative regulation of RIG-I antiviral activity. J Virol (2010) 84(7):3220-9. doi:10.1128/JVI.02241-09
24. Sun Z, Ren H, Liu Y, Teeling JL, Gu J. Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response. J Virol (2011) 85(2):1036-47. doi:10.1128/JVI.01734-10
25. Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, Grigorov B, et al. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell (2011) 147(2):423-35. doi:10.1016/j.cell.2011.09.039
26. Kolakofsky D, Kowalinski E, Cusack S. A structure-based model of RIG-I activation. RNA (2012) 18(12):2118-27. doi:10.1261/rna.035949.112
27. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature (2007) 446(7138):916-20. doi:10.1038/nature05732
28. Zeng W, Sun L, Jiang X, Chen X, Hou F, Adhikari A, et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell (2010) 141(2):315-30. doi:10.1016/j.cell.2010.03.029
29. Maharaj NP, Wies E, Stoll A, Gack MU. Conventional protein kinase C-alpha (PKC-alpha) and PKC-beta negatively regulate RIG-I antiviral signal transduction. J Virol (2012) 86(3):1358-71. doi:10.1128/JVI.06543-11
30. Oshiumi H, Miyashita M, Matsumoto M, Seya T. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog (2013) 9(8):e1003533. doi:10.1371/journal.ppat.1003533
31. Wies E, Wang MK, Maharaj NP, Chen K, Zhou S, Finberg RW, et al. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity (2013) 38(3):437-49. doi:10.1016/j.immuni.2012.11.018
32. Liu HM, Loo YM, Horner SM, Zornetzer GA, Katze MG, Gale M Jr. The mitochondrial targeting chaperone 14-3-3epsilon regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe (2012) 11(5):528-37. doi:10.1016/j.chom.2012.04.006
33. Wu B, Hur S. How RIG-I like receptors activate MAVS. Curr Opin Virol (2015) 12:91-8. doi:10.1016/j.coviro.2015.04.004
34. Matsumoto M, Oshiumi H, Seya T. Antiviral responses induced by the TLR3 pathway. Rev Med Virol (2011) 21(2):67-77. doi:10.1002/rmv.680
35. Hyun J, Kanagavelu S, Fukata M. A unique host defense pathway: TRIF mediates both antiviral and antibacterial immune responses. Microbes Infect (2013) 15(1):1-10. doi:10.1016/j.micinf.2012.10.011
36. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M, et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol (2004) 5(5):503-7. doi:10.1038/ni1061
37. Estornes Y, Toscano F, Virard F, Jacquemin G, Pierrot A, Vanbervliet B, et al. dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8. Cell Death Differ (2012) 19(9):1482-94. doi:10.1038/cdd.2012.22
38. Balachandran S, Thomas E, Barber GN. A FADD-dependent innate immune mechanism in mammalian cells. Nature (2004) 432(7015):401-5. doi:10.1038/nature03124
39. Lalani AI, Luo C, Han Y, Xie P. TRAF3: a novel tumor suppressor gene in macrophages. Macrophage (Houst) (2015) 2:e1009. doi:10.14800/macrophage.1009
40. Gori-Savellini G, Valentini M, Cusi MG. Toscana virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. J Virol (2013) 87(12):6660-7. doi:10.1128/JVI.03129-12
41. Gori Savellini G, Gandolfo C, Cusi MG. Truncation of the C-terminal region of Toscana virus NSs protein is critical for interferon-beta antagonism and protein stability. Virology (2015) 486:255-62. doi:10.1016/j.virol.2015.09.021
42. Zhu Z, Wang G, Yang F, Cao W, Mao R, Du X, et al. Foot-and-mouth disease virus viroporin 2B antagonizes RIG-I mediated antiviral effects by inhibition of its protein expression. J Virol (2016). doi:10.1128/JVI.01310-16
43. Hou Z, Zhang J, Han Q, Su C, Qu J, Xu D, et al. Hepatitis B virus inhibits intrinsic RIG-I and RIG-G immune signaling via inducing miR146a. Sci Rep (2016) 6:26150. doi:10.1038/srep26150
44. Chan YK, Gack MU. A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity. Nat Immunol (2016) 17(5):523-30. doi:10.1038/ni.3393
45. Miyashita M, Oshiumi H, Matsumoto M, Seya T. DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling. Mol Cell Biol (2011) 31(18):3802-19. doi:10.1128/MCB.01368-10
46. Oshiumi H, Miyashita M, Okamoto M, Morioka Y, Okabe M, Matsumoto M, et al. DDX60 is involved in RIG-I-dependent and independent antiviral responses, and its function is attenuated by virus-induced EGFR activation. Cell Rep (2015) 11(8):1193-207. doi:10.1016/j.celrep.2015.04.047
47. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature (2011) 472(7344):481-5. doi:10.1038/nature09907
48. Goubau D, van der Veen AG, Chakravarty P, Lin R, Rogers N, Rehwinkel J, et al. Mouse superkiller-2-like helicase DDX60 is dispensable for type I IFN induction and immunity to multiple viruses. Eur J Immunol (2015) 45(12):3386-403. doi:10.1002/eji.201545794
49. He Z, Zhu X, Wen W, Yuan J, Hu Y, Chen J, et al. Dengue virus subverts host innate immunity by targeting adaptor protein MAVS. J Virol (2016) 90(16):7219-30. doi:10.1128/JVI.00221-16
50. Dong J, Xu S, Wang J, Luo R, Wang D, Xiao S, et al. Porcine reproductive and respiratory syndrome virus 3C protease cleaves the mitochondrial antiviral signalling complex to antagonize IFN-beta expression. J Gen Virol (2015) 96(10):3049-58. doi:10.1099/jgv.0.000257
51. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A (2005) 102(49):17717-22. doi:10.1073/pnas.0508531102
52. Ferreira AR, Magalhaes AC, Camoes F, Gouveia A, Vieira M, Kagan JC, et al. Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response. J Cell Mol Med (2016) 20(4):750-7. doi:10.1111/jcmm.12801
53. Huang C, Du Y, Yu Z, Zhang Q, Liu Y, Tang J, et al. Highly pathogenic porcine reproductive and respiratory syndrome virus Nsp4 cleaves VISA to impair antiviral responses mediated by RIG-I-like receptors. Sci Rep (2016) 6:28497. doi:10.1038/srep28497
54. Cao L, Ge X, Gao Y, Herrler G, Ren Y, Ren X, et al. Porcine epidemic diarrhea virus inhibits dsRNA-induced interferon-beta production in porcine intestinal epithelial cells by blockade of the RIG-I-mediated pathway. Virol J (2015) 12:127. doi:10.1186/s12985-015-0345-x
55. Shi CS, Qi HY, Boularan C, Huang NN, Abu-Asab M, Shelhamer JH, et al. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. J Immunol (2014) 193(6):3080-9. doi:10.4049/jimmunol.1303196
56. You F, Sun H, Zhou X, Sun W, Liang S, Zhai Z, et al. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat Immunol (2009) 10(12):1300-8. doi:10.1038/ni.1815
57. Hyun J, Ramos JC, Toomey N, Balachandran S, Lavorgna A, Harhaj E, et al. Oncogenic human T-cell lymphotropic virus type 1 tax suppression of primary innate immune signaling pathways. J Virol (2015) 89(9):4880-93. doi:10.1128/JVI.02493-14
58. Lui PY, Wong LY, Fung CL, Siu KL, Yeung ML, Yuen KS, et al. Middle east respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3. Emerg Microbes Infect (2016) 5:e39. doi:10.1038/emi.2016.33
59. Siu KL, Chan CP, Kok KH, Chiu-Yat Woo P, Jin DY. Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain. Cell Mol Immunol (2014) 11(2):141-9. doi:10.1038/cmi.2013.61
60. Cramer P, Muller CW. A firm hand on NFkappaB: structures of the IkappaBalpha-NFkappaB complex. Structure (1999) 7(1):R1-6. doi:10.1016/S0969-2126(99)80002-1
61. Yamamoto Y, Gaynor RB. IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci (2004) 29(2):72-9. doi:10.1016/j.tibs.2003.12.003
62. Kroll M, Margottin F, Kohl A, Renard P, Durand H, Concordet JP, et al. Inducible degradation of IkappaBalpha by the proteasome requires interaction with the F-box protein h-betaTrCP. J Biol Chem (1999) 274(12):7941-5. doi:10.1074/jbc.274.12.7941
63. Chen LF, Greene WC. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol (2004) 5(5):392-401. doi:10.1038/nrm1368
64. Huang L, Liu Q, Zhang L, Zhang Q, Hu L, Li C, et al. Encephalomyocarditis virus 3C protease relieves TRAF family member-associated NF-kappaB activator (TANK) inhibitory effect on TRAF6-mediated NF-kappaB signaling through cleavage of TANK. J Biol Chem (2015) 290(46):27618-32. doi:10.1074/jbc.M115.660761
65. Wang D, Fang L, Shi Y, Zhang H, Gao L, Peng G, et al. Porcine epidemic diarrhea virus 3C-like protease regulates its interferon antagonism by cleaving NEMO. J Virol (2016) 90(4):2090-101. doi:10.1128/JVI.02514-15
66. Wang D, Fang L, Wei D, Zhang H, Luo R, Chen H, et al. Hepatitis A virus 3C protease cleaves NEMO to impair induction of beta interferon. J Virol (2014) 88(17):10252-8. doi:10.1128/JVI.00869-14
67. Wang D, Fang L, Li K, Zhong H, Fan J, Ouyang C, et al. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling. J Virol (2012) 86(17):9311-22. doi:10.1128/JVI.00722-12
68. Di Fiore IJ, Pane JA, Holloway G, Coulson BS. NSP1 of human rotaviruses commonly inhibits NF-kappaB signalling by inducing beta-TrCP degradation. J Gen Virol (2015) 96(Pt 7):1768-76. doi:10.1099/vir.0.000093
69. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol (2003) 4(5):491-6. doi:10.1038/ni921
70. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science (2003) 300(5622):1148-51. doi:10.1126/science.1081315
71. Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE (2006) 2006(357):re13. doi:10.1126/stke.3572006re13
72. Ikeda F, Hecker CM, Rozenknop A, Nordmeier RD, Rogov V, Hofmann K, et al. Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes. EMBO J (2007) 26(14):3451-62. doi:10.1038/sj.emboj.7601773
73. Verhelst K, Verstrepen L, Carpentier I, Beyaert R. IkappaB kinase epsilon (IKKepsilon): a therapeutic target in inflammation and cancer. Biochem Pharmacol (2013) 85(7):873-80. doi:10.1016/j.bcp.2013.01.007
74. Weil R, Laplantine E, Genin P. Regulation of TBK1 activity by optineurin contributes to cell cycle-dependent expression of the interferon pathway. Cytokine Growth Factor Rev (2016) 29:23-33. doi:10.1016/j.cytogfr.2016.03.001
75. Zhao W. Negative regulation of TBK1-mediated antiviral immunity. FEBS Lett (2013) 587(6):542-8. doi:10.1016/j.febslet.2013.01.052
76. Honda K, Taniguchi T. IRFs: master regulators of signalling by toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol (2006) 6(9):644-58. doi:10.1038/nri1900
77. Tamura T, Yanai H, Savitsky D, Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol (2008) 26:535-84. doi:10.1146/annurev.immunol.26.021607.090400
78. Ikushima H, Negishi H, Taniguchi T. The IRF family transcription factors at the interface of innate and adaptive immune responses. Cold Spring Harb Symp Quant Biol (2013) 78:105-16. doi:10.1101/sqb.2013.78.020321
79. Yoneyama M, Suhara W, Fukuhara Y, Fukuda M, Nishida E, Fujita T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J (1998) 17(4):1087-95. doi:10.1093/emboj/17.4.1087
80. Yang H, Ma G, Lin CH, Orr M, Wathelet MG. Mechanism for transcriptional synergy between interferon regulatory factor (IRF)-3 and IRF-7 in activation of the interferon-β gene promoter. Eur J Biochem (2004) 271(18):3693-703. doi:10.1111/j.1432-1033.2004.04310.x
81. Yang Y, Ye F, Zhu N, Wang W, Deng Y, Zhao Z, et al. Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets. Sci Rep (2015) 5:17554. doi:10.1038/srep17554
82. Christensen MH, Jensen SB, Miettinen JJ, Luecke S, Prabakaran T, Reinert LS, et al. HSV-1 ICP27 targets the TBK1-activated STING signalsome to inhibit virus-induced type I IFN expression. EMBO J (2016) 35(13):1385-99. doi:10.15252/embj.201593458
83. Zhang D, Su C, Zheng C. Herpes simplex virus 1 serine protease VP24 blocks the DNA-sensing signal pathway by abrogating activation of interferon regulatory factor 3. J Virol (2016) 90(12):5824-9. doi:10.1128/JVI.00186-16
84. Dalrymple NA, Cimica V, Mackow ER. Dengue virus NS proteins inhibit RIG-I/MAVS signaling by blocking TBK1/IRF3 phosphorylation: dengue virus serotype 1 NS4A is a unique interferon-regulating virulence determinant. MBio (2015) 6(3):e515-53. doi:10.1128/mBio.00553-15
85. Ding Z, Fang L, Jing H, Zeng S, Wang D, Liu L, et al. Porcine epidemic diarrhea virus nucleocapsid protein antagonizes beta interferon production by sequestering the interaction between IRF3 and TBK1. J Virol (2014) 88(16):8936-45. doi:10.1128/JVI.00700-14
86. Diani E, Avesani F, Bergamo E, Cremonese G, Bertazzoni U, Romanelli MG. HTLV-1 Tax protein recruitment into IKKepsilon and TBK1 kinase complexes enhances IFN-I expression. Virology (2015) 476:92-9. doi:10.1016/j.virol.2014.12.005
87. Yuen CK, Chan CP, Fung SY, Wang PH, Wong WM, Tang HM, et al. Suppression of type I interferon production by human T-cell leukemia virus type 1 oncoprotein tax through inhibition of IRF3 phosphorylation. J Virol (2016) 90(8):3902-12. doi:10.1128/JVI.00129-16
88. Masatani T, Ozawa M, Yamada K, Ito N, Horie M, Matsuu A, et al. Contribution of the interaction between the rabies virus P protein and I-kappa B kinase to the inhibition of type I IFN induction signalling. J Gen Virol (2016) 97(2):316-26. doi:10.1099/jgv.0.000362
89. Luo J, Fang L, Dong N, Fang P, Ding Z, Wang D, et al. Porcine deltacoronavirus (PDCoV) infection suppresses RIG-I-mediated interferon-beta production. Virology (2016) 495:10-7. doi:10.1016/j.virol.2016.04.025
90. Kotla S, Gustin KE. Proteolysis of MDA5 and IPS-1 is not required for inhibition of the type I IFN response by poliovirus. Virol J (2015) 12:158. doi:10.1186/s12985-015-0393-2
91. Huang F, Yang C, Yu W, Bi Y, Long F, Wang J, et al. Hepatitis E virus infection activates signal regulator protein alpha to down-regulate type I interferon. Immunol Res (2016) 64(1):115-22. doi:10.1007/s12026-015-8729-y
92. Zhang R, Fang L, Wu W, Zhao F, Song T, Xie L, et al. Porcine bocavirus NP1 protein suppresses type I IFN production by interfering with IRF3 DNA-binding activity. Virus Genes (2016) 52(6):797-805. doi:10.1007/s11262-016-1377-z
93. Burysek L, Yeow WS, Lubyova B, Kellum M, Schafer SL, Huang YQ, et al. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol (1999) 73(9):7334-42.
94. Seo T, Lee D, Lee B, Chung JH, Choe J. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) binds to, and inhibits transactivation of, CREB-binding protein. Biochem Biophys Res Commun (2000) 270(1):23-7. doi:10.1006/bbrc.2000.2393
95. Morin G, Robinson BA, Rogers KS, Wong SW. A rhesus rhadinovirus viral interferon (IFN) regulatory factor is virion associated and inhibits the early IFN antiviral response. J Virol (2015) 89(15):7707-21. doi:10.1128/JVI.01175-15
96. Zhang Q, Shi K, Yoo D. Suppression of type I interferon production by porcine epidemic diarrhea virus and degradation of CREB-binding protein by nsp1. Virology (2016) 489:252-68. doi:10.1016/j.virol.2015.12.010
97. Bauhofer O, Summerfield A, Sakoda Y, Tratschin JD, Hofmann MA, Ruggli N. Classical swine fever virus Npro interacts with interferon regulatory factor 3 and induces its proteasomal degradation. J Virol (2007) 81(7):3087-96. doi:10.1128/JVI.02032-06
98. Seago J, Hilton L, Reid E, Doceul V, Jeyatheesan J, Moganeradj K, et al. The Npro product of classical swine fever virus and bovine viral diarrhea virus uses a conserved mechanism to target interferon regulatory factor-3. J Gen Virol (2007) 88(Pt 11):3002-6. doi:10.1099/vir.0.82934-0
99. Gottipati K, Holthauzen LM, Ruggli N, Choi KH. Pestivirus Npro directly interacts with interferon regulatory factor 3 (IRF3) monomer and dimer. J Virol (2016) 90(17):7740-7. doi:10.1128/JVI.00318-16
100. Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J Virol (2013) 87(3):1690-8. doi:10.1128/JVI.01855-12
101. Xiang Z, Liu L, Lei X, Zhou Z, He B, Wang J. 3C protease of enterovirus D68 inhibits cellular defense mediated by interferon regulatory factor 7. J Virol (2016) 90(3):1613-21. doi:10.1128/JVI.02395-15
102. Zhang BC, Zhou ZJ, Sun L. pol-miR-731, a teleost miRNA upregulated by megalocytivirus, negatively regulates virus-induced type I interferon response, apoptosis, and cell cycle arrest. Sci Rep (2016) 6:28354. doi:10.1038/srep28354
103. de Weerd NA, Nguyen T. The interferons and their receptors-distribution and regulation. Immunol Cell Biol (2012) 90(5):483-91. doi:10.1038/icb.2012.9
104. Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem (2007) 282(28):20059-63. doi:10.1074/jbc.R700016200
105. Reich NC. STATs get their move on. JAKSTAT (2013) 2(4):e27080. doi:10.4161/jkst.27080
106. Au-Yeung N, Mandhana R, Horvath CM. Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway. JAKSTAT (2013) 2(3):e23931. doi:10.4161/jkst.23931
107. Fink K, Grandvaux N. STAT2 and IRF9: beyond ISGF3. JAKSTAT (2013) 2(4):e27521. doi:10.4161/jkst.27521
108. Porritt RA, Hertzog PJ. Dynamic control of type I IFN signalling by an integrated network of negative regulators. Trends Immunol (2015) 36(3):150-60. doi:10.1016/j.it.2015.02.002
109. Xia C, Vijayan M, Pritzl CJ, Fuchs SY, McDermott AB, Hahm B. Hemagglutinin of influenza A virus antagonizes type I interferon (IFN) responses by inducing degradation of type I IFN receptor 1. J Virol (2016) 90(5):2403-17. doi:10.1128/JVI.02749-15
110. Lubick KJ, Robertson SJ, McNally KL, Freedman BA, Rasmussen AL, Taylor RT, et al. Flavivirus antagonism of type I interferon signaling reveals prolidase as a regulator of IFNAR1 surface expression. Cell Host Microbe (2015) 18(1):61-74. doi:10.1016/j.chom.2015.06.007
111. Guo L, Luo X, Li R, Xu Y, Zhang J, Ge J, et al. Porcine epidemic diarrhea virus infection inhibits interferon signaling by targeted degradation of STAT1. J Virol (2016) 90(18):8281-92. doi:10.1128/JVI.01091-16
112. Pisanelli G, Laurent-Rolle M, Manicassamy B, Belicha-Villanueva A, Morrison J, Lozano-Dubernard B, et al. La Piedad Michoacan Mexico Virus V protein antagonizes type I interferon response by binding STAT2 protein and preventing STATs nuclear translocation. Virus Res (2016) 213:11-22. doi:10.1016/j.virusres.2015.10.027
113. Hastings AK, Amato KR, Wen SC, Peterson LS, Williams JV. Human metapneumovirus small hydrophobic (SH) protein downregulates type I IFN pathway signaling by affecting STAT1 expression and phosphorylation. Virology (2016) 494:248-56. doi:10.1016/j.virol.2016.04.022
114. Verweij MC, Wellish M, Whitmer T, Malouli D, Lapel M, Jonjic S, et al. Varicella viruses inhibit interferon-stimulated JAK-STAT signaling through multiple mechanisms. PLoS Pathog (2015) 11(5):e1004901. doi:10.1371/journal.ppat.1004901
115. Kint J, Dickhout A, Kutter J, Maier HJ, Britton P, Koumans J, et al. Infectious bronchitis coronavirus inhibits STAT1 signaling and requires accessory proteins for resistance to type I interferon activity. J Virol (2015) 89(23):12047-57. doi:10.1128/JVI.01057-15
116. Wu J, Chen X, Ye H, Yao M, Li S, Chen L. Nonstructural protein (NS1) of human parvovirus B19 stimulates host innate immunity and blunts the exogenous type I interferon signaling in vitro. Virus Res (2016) 222:48-52. doi:10.1016/j.virusres.2016.06.004
117. Chaudhary V, Zhang S, Yuen KS, Li C, Lui PY, Fung SY, et al. Suppression of type I and type III IFN signalling by NSs protein of severe fever with thrombocytopenia syndrome virus through inhibition of STAT1 phosphorylation and activation. J Gen Virol (2015) 96(11):3204-11. doi:10.1099/jgv.0.000280
118. Ning YJ, Feng K, Min YQ, Cao WC, Wang M, Deng F, et al. Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies. J Virol (2015) 89(8):4227-36. doi:10.1128/JVI.00154-15
119. Alexander WS, Hilton DJ. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol (2004) 22:503-29. doi:10.1146/annurev.immunol.22.091003.090312
120. Ilangumaran S, Ramanathan S, Rottapel R. Regulation of the immune system by SOCS family adaptor proteins. Semin Immunol (2004) 16(6):351-65. doi:10.1016/j.smim.2004.08.015
121. Sharma N, Kumawat KL, Rastogi M, Basu A, Singh SK. Japanese encephalitis virus exploits the microRNA-432 to regulate the expression of suppressor of cytokine signaling (SOCS) 5. Sci Rep (2016) 6:27685. doi:10.1038/srep27685
122. Choi EJ, Lee CH, Shin OS. Suppressor of cytokine signaling 3 expression induced by varicella-zoster virus infection results in the modulation of virus replication. Scand J Immunol (2015) 82(4):337-44. doi:10.1111/sji.12323
123. Zheng J, Yang P, Tang Y, Pan Z, Zhao D. Respiratory syncytial virus nonstructural proteins upregulate SOCS1 and SOCS3 in the different manner from endogenous IFN signaling. J Immunol Res (2015) 2015:738547. doi:10.1155/2015/738547
124. Walsh D, Mohr I. Viral subversion of the host protein synthesis machinery. Nat Rev Microbiol (2011) 9(12):860-75. doi:10.1038/nrmicro2655
125. Kint J, Langereis MA, Maier HJ, Britton P, van Kuppeveld FJ, Koumans J, et al. Infectious bronchitis coronavirus limits interferon production by inducing a host shutoff that requires accessory protein 5b. J Virol (2016) 90(16):7519-28. doi:10.1128/JVI.00627-16
126. Katsoulidis E, Kaur S, Platanias LC. Deregulation of interferon signaling in malignant cells. Pharmaceuticals (Basel) (2010) 3(2):406-18. doi:10.3390/ph3020406